Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril
Authors:
- John D. IrvinJIJohn D. Irvin
- 1 October 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 81 (4) , 46-50
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Adverse effects profile of sulfhydryl compounds in manThe American Journal of Medicine, 1986
- EnalaprilDrugs, 1985
- Review of the Overall Experience of Captopril in HypertensionArchives of internal medicine (1960), 1984
- Pharmacokinetics of repeated single oral doses of enalapril maleate (mk‐421) in normal volunteersBiopharmaceutics & Drug Disposition, 1984
- Captopril-Associated NeutropeniaArchives of internal medicine (1960), 1983
- Enalapril maleate and a lysine analogue (MK‐521): disposition in man.British Journal of Clinical Pharmacology, 1982
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977